Skip to main content
main-content

11-17-2020 | Heart failure | Commentary

Takeaways from the SCORED and SOLOIST-WHF trials

Deepak Bhatt discusses the performance of sotagliflozin in trials focusing on acute heart failure and on chronic kidney disease (11:56).

Image Credits